Do you want to read an article? Please log in or register.
Dilation Modifies Association Between Symptoms and Esophageal Eosinophilia in Adult Patients With Eosinophilic Esophagitis
Esophagus Diseases
Related content
Esophagus Diseases
Oral delivery of fluticasone powder improves esophageal eosinophilic inflammation and symptoms in adults with eosinophilic esophagitis
Dis Esophagus.
Kia L, Nelson M, Zalewski A, Gregory D, Gonsalves N, Straumann A, Hirano I
doi: 10.1093/dote/doy098.
RECOMMENDED
Esophagus Diseases
Systematic Assessment of Adult Patients' Satisfaction with Various Eosinophilic Esophagitis Therapies
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Int Arch Allergy Immunol.
Safroneeva E, Hafner D, Kuehni CE, Zwahlen M, Trelle S, Biedermann L, Greuter T, Vavricka SR, Straumann A, Schoepfer AM
doi: 10.1159/000504846.
Esophagus Diseases
Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis
Gastrointest Endosc
Schoepfer AM, Henchoz S, Biedermann L, Schreiner P, Greuter T, Reinhard A, Senn J, Franke A, Burri E, Juillerat P, Simon HU, Straumann A, Safroneeva E, Godat S
doi: 10.1016/j.gie.2021.05.017
Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms
Am J Gastroenterol.
Schoepfer AM, Simko A, Bussmann C, Safroneeva E, Zwahlen M, Greuter T, Biedermann L, Vavricka S, Godat S, Reinhard A, Saner C, Maye H, Sempoux C, Brunel C, Blanchard C, Simon D, Simon HU, Straumann A
doi: 10.1038/ajg.2017.493.
Esophagus Diseases
Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis
Gastroenterology.
Hirano I, Furuta GT
doi: 10.1053/j.gastro.2019.09.052.
An In-Depth Characterization of a Large Cohort of Adults Patients with Eosinophilic Esophagitis
Ann Allergy Asthma Immunol.
Leigh LY, Spergel JM
doi: 10.1016/j.anai.2018.09.452.
Esophagus Diseases
Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomes
Aliment Pharmacol Ther.
Safroneeva E, Balsiger L, Hafner D, Kuehni CE, Zwahlen M, Trelle S, Godat S, Biedermann L, Greuter T, Vavricka S, Straumann A, Schoepfer AM
doi: 10.1111/apt.15000.
Esophagus Diseases
Persistent Basal Cell Hyperplasia is Associated with Clinical and Endoscopic Findings in Patients With Histologically Inactive Eosinophilic Esophagitis
Clin Gastroenterol Hepatol.
Whelan KA, Godwin BC, Wilkins B, Elci OU, Benitez A, DeMarshall M, Sharma M, Gross J, Klein-Szanto AJ, Liacouras CA, Dellon ES, Spergel JM, Falk GW, Muir AB, Nakagawa H
doi: 10.1016/j.cgh.2019.08.055.
COMMENTED
Esophagus Diseases
Clinical and molecular factors associated with histologic response to topical steroid treatment in patients with eosinophilic esophagitis
Clin Gastroenterol Hepatol.
Eluri S, Selitsky SR, Perjar I, Hollyfield J, Betancourt R, Randall C, Rusin S, Woosley JT, Shaheen NJ, Dellon ES
doi: 10.1016/j.cgh.2018.09.005.